BioCentury
ARTICLE | Clinical News

Integra LifeSciences Corp. regulatory update

October 6, 1997 7:00 AM UTC

The Burnham Institute (La Jolla, Calif.) received U.S. Patent No. 5,654,267 covering the combining of peptides that bind the alpha-v-beta-3 integrin with platelet-derived growth factors, insulin growt...